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Objective: A prospective descriptive study to assess acceptability and effectiveness of a locally 
made ready-to-use therapeutic food (RUTF) in HIV-infected chronically sick adults (CSA) with 
mid-upper-arm circumference (MUAC)  210 mm or pitting edema.
Methods: Sixty-three wasted AIDS adults were prescribed 500 g representing ~2600 kcal/day 
of locally made RUTF for three months and routine cotrimoxazole. Weight, height, MUAC, 
Karnofsky score and morbidity were measured at admission and at monthly intervals. The 
amount of RUTF intake and acceptability were assessed monthly.
Results: Ninety-ﬁ  ve percent (60/63) of the CSA that were invited to join the study agreed to 
participate. Mean daily intake in these 60 patients was 300 g/person/day (~1590 Kcal and 40 g 
of protein). Overall, 73.3% (44/60) gained weight, BMI, and MUAC. The median weight, 
MUAC and BMI gains after three months were 3.0 kg, 25.4 mm, and 1.1 kg/m2, respectively. 
The intervention improved the physical activity performance of participants and 78.3% (47/60) 
regained sufﬁ  cient strength to walk to the nearest health facility. Mortality at three months was 
18.3% (11/60).
Conclusion: Locally made RUTF was acceptable to patients and was associated with a rapid 
weight gain and physical activity performance. The intervention is likely to be more cost effective 
than nutritional support using usual food-aid commodities.
Keywords: ready-to-use therapeutic food, community-based intervention, adult, supplementation, 
HIV, Malawi
Introduction
In human immunodeﬁ  ciency virus (HIV)-infected patients, malnutrition is associated 
with an increased risk of death and studies in industrialized countries have demonstrated 
that weight loss is a good predictor of both opportunistic infection and death.1–3 Similar 
results have been reported from developing countries including in patients on highly 
active antiretroviral therapy (HAART).4–6
In industrialized countries, wasting is an indication of progression to acquired 
immune deﬁ  ciency syndrome (AIDS), generally occurring as part of the wasting 
syndrome and closely correlated with stage of the disease.7 By contrast, analysis of 
anthropometric data from a high prevalence HIV population in South Africa showed 
that there was no association between disease stage and nutritional status, suggesting 
that malnutrition due to food shortage might have played an important role in the 
occurrence of wasting.8
For the World Health Organization (WHO), the comprehensive care for PLWHA 
must include nutritional support.9 WHO recommends that symptomatic HIV and 
AIDS patients to increase their daily energy intake by 50% from the requirements of 
normal active HIV negative adult of 2430 Kcal for male and 2170 kcal for female 
but to keep proteins and vitamins and minerals intakes at normal daily requirement.9 Patient Preference and Adherence 2009:3 68
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Thus, the daily recommended energy and proteins intake 
for symptomatic PLWHA are 2910 to 3160 kcal and 57 g of 
proteins for male and 2600 to 2820 kcal and 48 g of proteins 
for female to just maintain weight.10 The most widespread 
nutrition intervention for HIV-positive adults in developing 
countries consists of nutrition counseling and the distribution 
of corn soy blend (CSB; a blended ﬂ  our) and vegetable oil. 
However, a study in Malawi indicates that this type of support 
does little to improve the nutritional status or the survival of 
HIV-infected people.11 By contrast, data does exist showing 
the effectiveness in HIV-positive malnourished children of 
ready-to-use therapeutic food (RUTF).12
The pilot program described in this paper aimed at 
assessing the effectiveness of RUTF made out of local crops 
without the addition of milk powder, for the nutritional 
support of sick HIV-positive adults in Malawi.
Methods
Subjects
The research was conducted in the central region of Malawi 
from May 2005 to October 2005 in collaboration with 
SASO (Salima AIDS Support Organization) and NASO 
(Nkhotakota AIDS Support Organization), home-based care 
organizations (HBC).
People already receiving care from the NASO and SASO 
HBC programs were eligible for enrolment in the study. 
Entry criteria were a middle-upper-arm circumference 
(MUAC) below 210 mm, a body mass index (BMI) below 
17 kg/m2, bilateral pitting edema of the feet or legs or bed-
ridden for  50% of the daytime for more than one month. 
Exclusion criteria were conﬁ  rmed HIV-negative, long term 
physical disability and inability to eat.
Protocols
Possible candidates identiﬁ  ed by the volunteers were visited 
by the HBC supervisors and the study research team, who 
conﬁ  rmed eligibility, explained the study objectives and pro-
cedures and presented a consent form for signing if willing to 
participate. At admission, MUAC, weight, height, presence 
of bilateral edema and physical activity performance using 
the Karnofsky score were assessed.13 A brief medical history 
and physical examination was conducted to assess the WHO 
clinical HIV stage and identify existing morbidity. In those 
subjects who agreed to have capillary blood taken (n = 51), 
hemoglobin and CD4 count were measured using a portable 
hemoglobin meter (hemoCue AB, Angelholm, Sweden) and 
immunophenotyping (EPICS or FACS count Machine), 
respectively. All subjects were followed up monthly.
Dietary and medical treatment
Subjects received two pots (500 g) of chickpea sesame-based 
RUTF (CS-RUTF) providing 2600 kilocalories, 61.5 g of 
proteins and  1 recommended dietary intake (RDI) for all 
the vitamins and minerals per day for three months (Table 1). 
The composition in vitamins and minerals was based on 
WHO speciﬁ  cations for RUTF.14 In addition, 960 mg daily 
prophylaxis dose of cotrimoxazole was provided along with 
treatment for minor diseases. More severe medical conditions 
were referred to the HBC clinic or district hospital.
Data collection and analysis
At admission and during follow up visits, RUTF intake and 
acceptability, patient complaints, signs and symptoms of 
disease and nutritional status were assessed. The acceptability 
of the CS-RUTF was determined through discussion with 
patients and caretakers. Intake of RUTF was determined by 
counting the number of ﬁ  nished pots.
Patient information was recorded on individual cards and 
entered into a database using Epi Info version 6 (Centers for 
Disease Control and Prevention, Atlanta, GA). Analyses were 
performed using SPSS version 12 (SPSS Inc., Chicago, IL). 
The outcomes of interest were: MUAC, weight, BMI, and 
physical activity performance changes. MUAC, BMI, and 
weight change were calculated by subtracting the value at 
admission from the value at one, two, and three months of 
treatment. Physical activity performance changes were based 
on the Karnofsky score (KS)13 that we used to deﬁ  ne four 
categories of physical activity performance and ability to 
accomplish activities of daily living. These categories were: 
able to carry out all pre-disease activities (KS  = 80%); 
restricted in strenuous activity but ambulatory and able to 
care for self (KS of 70%); very reduced activity, inability to 
walk long distances or to carry out normal activity but able 
to care for self (KS of 60% or 50%); disabled, bedridden and 
requires considerable amount of assistance (KS   40%).
Quantitative data for normally distributed variables were 
described using means and standard deviation (SD) and 
compared using Student’s t-test; nonnormally distributed 
variables were described using median and inter-quartile 
range (IQR) and compared using the Kruskall–Wallis test. 
The association between weight, MUAC, BMI gains, and 
total RUTF intake were explored using the bivariate correla-
tion analysis (Pearson correlation) with stepwise multivariate 
linear regression analysis used to explore the independence of 
the relationships. The predictors for the multivariate models 
were selected from a pool of pre-chosen potential predictors 
that included sex (potential inﬂ  uence of energy differences in Patient Preference and Adherence 2009:3 69
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requirements and expenditure), Weight, MUAC, and BMI of 
admission (the extend of weight gain is usually related to the 
initial deﬁ  cit of body mass), presence of edema (as edema 
could inﬂ  uence mortality and also minimize weight gain 
even when using lowest weight) and the morbidity during 
treatment (as diseases can interfere with utilization of nutri-
ents and increase energy expenditure). Many other variables 
were tested and retained in the models if they helped in the 
reduction of the residual variance. The Wilcoxon test and 
McNemar test for paired samples were used in the analysis 
of change in physical activity performance.
Results
One hundred twenty HBC patients selected by volunteers 
were assessed for the program and 71 of these met criteria 
for admission. Out of the 71, five were moribund and 
excluded from the study (see Figure 1). Of the 66 remaining, 
63 (95.5%) agreed to participate. Two refused to join the 
program because of fear of stigmatization and one on the 
advice of a traditional healer. Three of those who started to 
take RUTF were later conﬁ  rmed as HIV-negative, leaving a 
total of 60 for the study analysis.
Description of subjects
The median age of the patients was 37.7 years (29.7–44) 
and 63.3% (38/60) of them were female. Clinically, 
75% (45/60) had WHO HIV stage 4% and 25% HIV 
stage 3, but HIV infection was conﬁ  rmed serologically 
at the time of inclusion in only 55% (33/60). 100% had 
reduced physical activity performance (Table 2). 26.7% 
Table 1 CS-RUTF composition and content and comparison of prescribed amount and the recommended daily intake
Ingredients/Nutrients CS-RUTF RDI Content of 500 mg of CS-RUTF
Amount g 100 500.0
Ingredients
Vegetable oil g 20.0
Sugar g 15.0
Sesame seeds g 22.4
Chickpeas g 36.0
Maize g 5.0
Complex of vitamins and minerals g 1.6
Content
Energy kcal 536.2 2600–3160 2681.0
Proteins g 12.3 48–57 61.5
Vit. A μg 816.9 600 4084.5
Vit. D μg 14.6 5 73.0
Vit. E mg 18.2 10 91.0
Vit. B1 mg 0.6 1.4 3.0
Vit. B2 mg 1.7 1.6 8.5
Niacin (Vit B3) mg 4.8 18 24.0
Pantothenic Acid (Vit B5) mg 2.8 6 14.0
Vit. B6 mg 0.5 2 2.5
Biotin μg 59.5 30 297.5
Total Folic Acid μg 191.7 400 958.5
Vit. B12 μg 1.6 6 8.0
Vit. C mg 48.3 75 241.5
Calcium mg 304.1 1000 1520.5
Copper mg 1.7 2 8.5
Iodine μg 92.7 150 463.5
Iron mg 10.5 15 52.5
Phosphorus mg 351 1000 1755.0
Potassium mg 935.6 3500 4678.0
Zinc mg 12.4 15 62.0
Abbreviations: RUTF, ready-to-use therapeutic food; CMV, complex of vitamin and minerals; RDI, recommended daily intake.Patient Preference and Adherence 2009:3 70
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(16/60) had commenced cotrimoxazole prophylaxis at 
the time of admission, and 13.3% (8/60) had started 
antiretroviral (ARV) therapy with a combination of 
stavudine, lamivudine, and nevirapine. These eight 
patients had been on ARV for one to two months prior to 
inclusion in the study (Table 2). At admission, the over-
all average weight was 41.6 (7.3) kg, 23.3% (14/60) of 
patients had edema, 78.3% (47/60) had a MUAC of less 
than 210 mm (overall mean ± SD of 195.0 ± 18.8 mm), 
69% (40/58) had a BMI of less than 17 kg/m2 (overall 
mean ± SD of 16.1 ± 1.7 kg/m2) and 50% (29/58) a BMI 
less than 16 kg/m2. Medical complaints at admission 
were dominated by fever, but diarrhea, oral candidiasis 
and dermatitis were also common (Table 2). The mean 
hemoglobin was 9.3 (1.8) g/dl and the median CD4 count 
was 182 (54–310) cells/μl. Patients already on ARVs 
at admission had lower average weight [35.9 (3.9) kg 
for those on ARV versus 42.4 (7.3) kg for those not on 
ARVs; p = 0.017], lower average MUAC [184.1 (22.7) mm 
for those on ARVs compared to 196.7 (17.8) mm for 
those not on ARVs; p = 0.79] and lower average BMI 
[14.9 (1.4) kg/m2 for those on ARV compared to 16.3 
(1.6) kg/m2 for those not on ARVs; p = 0.26] than those 
not yet on ARVs. The mean age, the sex distribution, the 
mean hemoglobin, the mean CD4 count, the proportion 
of those with edema and the proportions of bedridden of 
those on ARVS at admission were not different to that of 
those not on ARVs (data not shown).
Morbidity and mortality during follow-up
Seventy percent (42/60) completed the program, 3.3%  (2/60) 
moved from the area, 8.3% (5/60) defaulted, and 18.3% 
(11/60) died within the three months of follow-up with a 
median (IQR) time to death of 46 days (22–70). Two deaths 
occurred in patients already nutritionally stabilized and who 
had resumed normal activity. During the three months of 
follow up, 37 of 55 patients (67.3%) reported or presented 
at least once with a new episode of diarrhea, fever, cough, 
oral thrush, headache, or abdominal pain.
RUTF intake and impact on nutrition status
The median (IQR) daily intake of RUTF amongst the 
subjects included in the program was 300 (150–400) g/
person/day (1,590 kcal and ~40 g protein per/person/day). 
Overall, 73.3% (44/60) gained weight and BMI during the 
intervention. The median (IQR) of weight, MUAC, and 
BMI gain were 2.5 (0.4–6.0) kg, 15 (0.0–28.0) mm, and 0.8 
(−0.2–1.8), respectively. The weight gain (SD) per 1000 kcal 
provided was 19.1 (86.9) g (n = 54).
The total RUTF intake predicted the MUAC, weight and 
BMI changes (Figure 2) (Pearson correlation coefﬁ  cient = 0.503 
(p   0.001), 0481 (p   0.001) and 0.458 (p = 0.001), 
respectively). RUTF intake was independently and positively 
associated with change in MUAC, weight, and BMI in multi-
variate models that adjusted for sex, admission characteristics 
(including MUAC, BMI, bilateral pitting edema, Karnofsky 
score, HIV clinical stage, and presence of diarrhea) and mor-
bidity encountered during the program (nausea, abdominal 
pain, cough, headache, diarrhea, and fever) (Table 3). The 
models indicate that commencing ARV triple therapy prior to 
entering the program or whilst in the program also positively 
affected MUAC, weight, and BMI gains. Headache and cough 
during the three months of the program reduced weight gain. 
The multivariate models explained 37.9%, 52.8%, and 52.8% 
Figure 1 Flowchart for the participation in the program.
Assessed for inclusion
n = 71
HIV negative 
n = 3
Refusals
n = 3 
Included 
n = 60
Absconded 
n = 5
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n = 2
Completed
n = 42
Died
n = 11
Referred to hospital 
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of the variability of the change in MUAC, weight, and BMI, 
respectively (Table 3).
Impact on physical activity performance
The proportion of patients able to walk to the clinic increased 
from 41.7% (25/60) at admission to 78.3% (47/60) at three 
months (p < 0.001). Overall, the intervention improved the 
Karnofsky score of 73.3% (44/60) of participants with 36.7% 
(22/60) improving by one category, 26.7% (16/60) improving 
by two categories, and 10.0% (6/60) improving by three 
categories. 80.1% (34/42) of the subjects who completed the 
three months of intervention had a Karnofsky score  80%, 
allowing them to resume their previous activities. 9.5% (4/42) 
still required external assistance for their personal care. Out 
of the 25 patients bedridden at admission who completed the 
three-month study, 88% (22/25) were able to resume their 
normal activity before commencing ART while 12% (3/22) 
were still bedridden.
Discussion
Acceptability of RUTF
These results indicate that locally made CS-RUTF was 
acceptable to HIV-positive patients. Although, some patients 
linked gastrointestinal symptoms to CS-RUTF intake, these 
symptoms did not inﬂ  uence the intake of CS-RUTF. This 
ﬁ  nding suggests that these symptoms were minor or that 
patients were encouraged to overcome them because of the 
improvement of their health status as a result of the CS-RUTF 
intervention. Also, the symptoms reported by the participants 
are common in HBC patients and tend to reoccur.15
Effectiveness
CS-RUTF intake was associated with a considerable 
improvement in physical activity performance and nutritional 
status. The high degree of impact demonstrated in this study 
stands in marked contrast to other intervention studies that 
have examined the impact of traditional food aid commodi-
ties on nutritional status and survival amongst chronically 
sick adults. An observational before and after study carried 
out at Bangwe (Malawi) that provided a monthly ration of 
7.5 kg of CSB, 50 kg of maize ﬂ  oor, 5 kg of beans ± 4 liters 
of fortiﬁ  ed vegetable oil for 18 months, demonstrated a BMI 
increase of only 0.17 kg/m2/100 days.11 Their conclusions 
were that food supplementation did not have a signiﬁ  cant 
impact.11 Similarly, in Uganda, Maina and colleagues found 
that nine months of food supplementation for chronically sick 
adults providing 300 g of CSB and 25 g of vitamin A fortiﬁ  ed 
vegetable oil per day (equivalent to 1333 kcal/person/day) 
Table 2 Characteristics and condition of patients at admission into 
the program
N%
Sex
Male 22 36.7%
Female 38 63.3%
Total 60 100.0%
Physical activity performance (KS)
KS 100% to 80% 0 0.0%
KS 70% 25 41.7%
KS 60% to 50% 22 36.7%
KS 40% or less 13 21.7%
Total 60 100.0%
Clinical HIV stage
Stage 3 14 23.3%
Stage 4 46 76.7%
Total 60 100.0%
Cotrimoxazole prophylaxis
Yes 16 26.7%
No 44 73.3%
Total 60 100.0%
MUAC categories
≥185 mm 44 73.3%
160–184 mm 14 23.3%
<160 mm 2 3.3%
Total 60 100.0%
BMI categories
≥18.5 7 12.1%
16–18.4 22 37.9%
<16 29 50.0%
Total 58 100.0%
Complaint of fever
Yes 42 70.0%
No 18 30.0%
Total 60 100.0%
Diarrhea
Present 15 25.0%
Absent 45 75.0%
Total 60 100.0%
Oral candidiasis
Present 9 15.3%
Absent 50 84.7%
Total 59 100.0%
Dermatitis
Present 13 15.3%
Absent 47 84.7%
Total 60 100.0%
Abbreviations: KS, Karnofsky score;  BMI, body mass index; HIV,  human immunodeﬁ  ciency 
virus; MUAC, mid-upper-arm circumference.Patient Preference and Adherence 2009:3 72
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Figure 2a–c Association between anthropometric change and RUTF intake
Abbreviations: ARV, antiretroviral; BMI, body mass index; MUAC, mid-upper-arm circumference; RUTF, ready-to-use therapeutic food.
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led to a weight gain and MUAC increment of only 2.06 kg 
and 0.99 cm, respectively.16
The three-month intervention providing 500 g/day of 
CS-RUTF achieved a tenfold greater increase in BMI than 
the 12 months of nutritional support described by Bowie 
and colleagues11 and double the weight and MUAC gains 
reported after the nine-month intervention in the Uganda 
study.16 Participants in this present study gained 19.1 g 
for each 1,000 Kcal of RUTF provided compared to only 
5.7 g/1000 Kcal provided in the Uganda study.
The use of high nutrient supplement was necessary as 
patients enrolled in the present study were severely wasted 
and needed therapeutic feeding rather than supplementary 
feeding. Indeed, compared to the normal MUAC, weight, and Patient Preference and Adherence 2009:3 73
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BMI of rural Malawian of 238 mm, 50.1 kg and 18.8 kg/m2 for 
male and 266 mm, 48.1 kg and 19.6 kg/m2 for female, some 
patients have lost up to 20% or more of their weight.17
The high nutrient density, especially the energy density 
of RUTF, the ease of use of RUTF, and the decreased pro-
pensity to share RUTF when compared with traditional aid 
commodities such as CSB, oil, and sugar, are probably all 
important factors contributing to the better impact of this 
study. The energy density of CS-RUTF is ~530 kcal/100 g 
and the average intake seen here of 300 g of RUTF per day 
provided 1590 kcal/day. By contrast, the energy density of 
porridge cooked in villages rarely exceeds 80 kcal/100 ml,18 
requiring at least 2.5 liters of a thick porridge to achieve 
an equivalent energy intake. The low nutrient density of 
relief foods also precludes diets based on these commodi-
ties achieving the nutrient densities recommended by the 
WHO for the treatment of severe acute malnutrition.19 An 
additional factor that might have contributed to the better 
outcome is less sharing of the RUTF than with traditional 
food-aid commodities. Anthropological studies looking at 
people’s acceptance of community-based therapeutic care 
have indicated that RUTF, although shared amongst the 
family, tends to be better targeted towards the individual 
undergoing treatment than blended ﬂ  our.20
Although we do not have pre-intervention data on mortal-
ity in PLWHA in the study areas, the observed three-month 
mortality of 18.3% in the patients included in the program 
seems relatively low given that 75% of the patients were in 
stage 4 and had wasting syndrome known to be associated 
with a median survival of only 9.3 months and 3.4 months, 
respectively.21–23
Cost effectiveness
The combination of improved energy and nutrient content, 
increased rates of weight gain, better targeting and shorter 
duration of treatment has important implications for cost 
effectiveness. Using the WFP-Malawi costing of $10 per 
person/month receiving CSB and oil, $40 /household/month 
for the household food support and $50/MT for operational 
costs, the monthly cost of the nutrition support was $53.25/
targeted patient using the standard food-aid commodities of 
CSB and oil. In our study the cost of RUTF was $3/kg and 
$50/MT for operational costs, equivalent to $45.9/month for 
the 500 g/day ration. The far shorter three-month duration 
of treatment meant that the total cost of the intervention was 
$137.7/patient, less than 20% of the cost of the Bangwe 
program at $629/patient and less than 25% the cost of the 
intervention in Uganda ($479.25/patient).
An important ﬁ  nding of this study is that two local AIDS 
support organizations were able to implement this type of 
intervention with little external support. Our support covered 
only training of the main supervisors and volunteers, the 
Table 3 Association between anthropometric changes and total RUTF intake
Variable β coefﬁ  cient 95% CI p R R2
Model for MUAC gain 0.623 0.389
Number of pots consumed 0.213 0.088–0.338 0.001
Started antiretroviral tritherapy 11.292 −0.071–22.656 0.051
≥1 episode of headache −15.007 −26.373– –3.650 0.011
Constant 7.602 −7.645–22.849 0.320
Model for weight gain 0.727 0.528
Number of pots consumed 0.045 0.019–0.070 0.001
Started antiretroviral tritherapy 4.835 2.196–7.474 0.001
≥1 episode of headache −3.346 −5.786– –0.906 0.008
≥1 episode of cough −2.746 −5.168– –0.323 0.027
Constant 1.943 −1.235– –5.120 0.224
Model for BMI gain 0.726 0.528
Number of pots consumed 0.017 0.005–0.028 0.005
Started antiretroviral tritherapy 2.035 1.005–3.065 <0.001
≥1 episode of headache −1.218 −2.227– –0.208 0.019
≥1 episode of cough −0.902 −1.887– 0.083 0.072
Constant 0.519 −0.954– 1.992 0.480
Abbreviations: BMI, body mass index; MUAC, mid-upper-arm circumference; RUTF, ready-to-use therapeutic food.Patient Preference and Adherence 2009:3 74
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delivery of CS-RUTF to the main ofﬁ  ce of NASO and SASO 
and provision of ﬁ  nancial support for drugs, fuel purchase 
and replenishment of the HBC kits.
Access to ARV services
The positive impact of the intervention on physical activity 
performance and well being had several important conse-
quences. During the course of the intervention 15 out of 
27 HIV untested patients who had been reluctant to consider 
voluntary counseling and HIV testing (VCT), changed 
their minds and underwent VCT. The increase in physical 
activity as a result of treatment also enabled many patients 
previously too weak to access their nearest clinic to walk to 
their clinic and qualify for admission into ART programs. 
This is an important outcome in a country where in 2004 
only approximately 17% of young adults had ever undergone 
HIV testing.24 In Malawi the low uptake of VCT means that 
in practice most HIV infections remain undiagnosed and 
are merely suspected on clinical grounds in chronically sick 
patients. As within developing countries, the time from ﬁ  rst 
AIDS-deﬁ  ning condition to death can be as short as nine 
months,21–23 this delayed diagnosis means that by the time 
that HIV is suspected many patients may no longer be able 
to walk to the nearest VCT centre and cannot therefore be 
enrolled into an ART program. This represents a barrier to 
accessing ARVs for a substantial number of adults and starts 
a vicious cycle wherein the patient is too weak to access 
appropriate care, becomes weaker and then loses hope. 
Findings from this study indicate that types of intervention 
have the potential to substantially increase access and uptake 
of ARV services.
Study limitations
The observational design and the absence of pre-intervention 
data for comparison are limitations to the study. Unfortunately, 
it was impossible to implement interventions that provided 
different types of nutritional support, as NASO and SASO 
authorities believed that this would create problems with their 
beneﬁ  ciaries. Another limitation of the study is the absence 
of data on food availability at household level and of dietary 
intake from other food. This data would have enabled us 
to control for impact of quality and quantity of household 
food and consumption of other food on study outcomes. 
However, as CS-RUTF intake correlated positively with 
the rate of nutritional recuperation, even after adjusting for 
potential confounding factors, it is reasonable to propose 
that a causal link exists between the two. The short time of 
follow up did not allow us to assess the impact of the early 
mortality after HAART commencement; a follow up study 
is going to address this question.
Conclusions
These results were obtained in HBC programs run by local 
volunteer organizations where, apart from the provision 
of free RUTF, no additional operational inputs were pro-
vided. The study has indicated that nutrition support with 
CS-RUTF was acceptable to the majority of patients and 
was associated with an improvement of the nutritional status 
measured using anthropometric parameters in the majority 
of HIV-positive patients with WHO clinical stage 3 and 
4 disease. The majority of subjects also experienced marked 
increases in physical capacity and well being that increased 
both access to and uptake of VCT and ART services. These 
results were achieved at a substantially reduced cost when 
compared to usual nutritional support using traditional food-
aid commodities. These results suggest that in the context 
of rural Malawi, the provision of RUTF should be a core 
component of HBC programs. Further work is required to 
investigate whether these results can be generalized to other 
contexts and to conﬁ  rm that the improvement in weight and 
physical activity performance correspond to a signiﬁ  cant 
gain in fat free mass.
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